City University of New York (CUNY)

CUNY Academic Works
Student Theses

John Jay College of Criminal Justice

Summer 9-10-2020

Effects of microwave radiation on the digestion of proteins
involved in body fluid identification
Aaron J. Fox
CUNY John Jay College, aaron.fox44@gmail.com

How does access to this work benefit you? Let us know!
More information about this work at: https://academicworks.cuny.edu/jj_etds/171
Discover additional works at: https://academicworks.cuny.edu
This work is made publicly available by the City University of New York (CUNY).
Contact: AcademicWorks@cuny.edu

Effects of microwave radiation on the digestion of proteins
involved in body fluid identification
A Thesis Presented in Partial Fulfillment of the Requirements for the Degree of
Master of Science in Forensic Science
John Jay College of Criminal Justice
The City University of New York

Aaron Joseph Fox
August 2020

Effects of microwave radiation on the digestion of proteins
involved in body fluid identification.
Aaron Joseph Fox

This thesis has been presented to and accepted by the office of Graduate Studies, John
Jay College of Criminal Justice in partial fulfillment of the requirements for the degree of
Master of Science in Forensic Science.

Thesis Committee:
Thesis Advisor: Dr. Richard Li
Second Reader: Dr. Artem Domashevskiy
Third Reader: Dr. Donald Siegel

Table of Contents

Pages

Acknowledgments

i

Abstract

ii

Introduction

1 – 19

Methods and Materials

20 – 29

Results

30 – 59

Discussion

60 – 71

References

72 – 77

Appendix

78 – 93

i
Acknowledgements
In working towards completion and submission of this thesis I have been
fortunate to have a very strong support group. I would first like to thank the New York
City Office of the Chief Medical Examiner (OCME), and more specifically Dr. Donald
Siegel. It was with his permission, and under his grant through the National Institute of
Justice, that permitted me to work on this project. His expertise and guidance provided
me the opportunity to perform this work in a high-quality lab setting. Dr. Heyi Yang,
also of the OCME, provided me many of the fundamental bench top lessons I would use
while working in the lab. My thesis advisor, Dr. Richard Li, was always available and
ready to help wherever needed to see this thesis to completion. Dr. Artem Domashevskiy
for providing valuable commentary while reviewing my thesis. Dr. Mechthild Prinz,
program director of the Master of Science in Forensic Science program at John Jay, for
providing detailed guidance and timelines to ensure completion of this thesis could be
met. My parents, Nancy and Terry, and my brother Ethan for always providing extra
motivation when this felt like it was becoming too much. To my dog Lucky, for always
providing a non-judgmental ear and distraction when I needed to think something
through. Lastly, and most importantly, I want to thank my wife Jordana. Without her
love, support and positive encouragement this would have been much more difficult to
complete.

ii
Abstract
Body fluid identification plays an important role in understanding how the events
during a crime may have taken place. The presence of a body fluid may help identify an
individual who committed a crime, while the type of body fluid present may help
investigators determine how a crime occurred. Current body fluid identification
techniques are not always conclusive and may only suggest the presence of a body fluid
type. A protocol developed by the New York City Office of the Chief Medical Examiner
(OCME) established a method that confirms body fluid type through mass spectrometry.
To identify marker proteins in a body fluid sample, the proteins in the sample must be
digested into their smaller peptide fragments. Currently, this digestion is performed with
trypsin in an overnight process that takes at least eight hours to complete. Microwave
radiation has been shown to assist in the digestion of the body fluid protein samples, and
the time needed for digestion reduced from eight hours to just minutes. The effects of
microwave radiation on the digestion of protein samples commonly found in body fluids
were examined here and compared to traditional methods. Ideal microwave assisted
temperature of protein samples was determined to be 37°C, however no significant
differences were observed between microwave assisted digestion and the traditional
methods of digestion at different incubation times. Overall, this research shows
microwave radiation can be used to assist protein digestion, achieving similar results to
traditional digestion methods at 37°C.
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Introduction
The presence and proper identification of the body fluids obtained from a crime
scene may be a pivotal piece of evidence assisting in forensic investigations.
Identification of a body fluid type at a crime scene plays an important role in defining
future testing of a sample and, ultimately, may influence the outcome of a case (Virkler
& Lednev, 2009). Many types of body fluids may be found at a given crime scene.
Blood, semen and saliva are the three most common body fluids found at a crime scene,
however menstrual blood, vaginal fluid, sweat and urine are found as well, and may play
an important role in the investigation (Harbison & Fleming, 2016). DNA typing from a
body fluid sample is one of the common means in which the ‘who’ of a crime may be
established. When performing DNA typing, however, the type of a body fluid present in a
sample may be just as important in determining the ‘what’, ‘where’ and ‘how’ of the
crime. Proper identification of the body fluid samples will also play an important role in
how this evidence will be processed further in the laboratory. Proper sample
identification saves time, money and ensures the preservation of a sample for potential
future testing.
Current analysis of body fluids involves two types of tests: presumptive and
confirmatory. Presumptive tests are highly sensitive in nature (high detectability)
however they may not necessarily be specific for a substance (may cross react with
different substances). In some cases, presumptive tests may result in a false positive,
which by most standards is acceptable as long as no false negatives are obtained (Houck
& Siegel, 2006). Contrary to presumptive, confirmatory tests typically involve tests that
are highly specific to a substance (will only test for the substance in question), however
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the test may not be as sensitive (requiring a larger amount of the substance to test). After
presumptive tests are performed, positive results for the substance in question will
typically lead to a confirmatory test. Confirmatory tests may produce false negatives, but
should not produce any false positives (Houck & Siegel, 2006). The current process of
presumptive and confirmatory tests is important in directing the flow of an investigation.
Presumptive tests tend to offer a quick screening method to locate “invisible” or
extremely small stains which may not be visible to the naked eye, as well as rule out
stains which may appear to be similar to body fluids but are in fact not (Carr, 2009).
Confirmatory tests on the other hand may be more time consuming, have higher
laboratory costs and may require more assessment by the analyst, i.e. microscopic
examination, DNA analysis or immunological testing.
Blood is one of the most common types of body fluids that may be found at a
crime scene; most methods of analysis and testing for body fluids, therefore, revolve
around blood. Presumptive tests for blood rely on the detection of hemoglobin
molecules. Colorimetric assays such as phenolphthalein and leucomalachite green use a
colorless dye that once exposed to heme will cause a chemical reaction and change color
to a pink or bluish green (Li, 2015). Similar to colorimetric tests, chemiluminescent tests
such as luminol test, will emit a fluorescent light when exposed to hemoglobin (Butler,
2005). Each of these tests is important for the screening and possible indication of blood
at a crime scene, however they are capable of cross reacting with other chemicals or
materials, potentially resulting in a false positive outcome (Carr, 2009). Confirmatory
tests need to be performed if blood presence is suspected. These tests involve crystal
formation when the sample is subjected to chemical treatment and heat (Houck & Siegel,
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2006). The Takayama crystal assay (hemochromogen test) uses pyridine under alkaline
conditions with a reducing sugar added to a presumed sample of blood on a microscope
slide. Heat is applied, and, if crystal formation is observed by means of a microscope,
then the presence of blood is confirmed (Houck & Siegel, 2006). Similarly, the
Teichmann crystal assay (Hematin crystal assay) uses the application of acetic acid and
salts introduced to a presumed blood sample. The sample is then heated, and if crystals
are observed under a microscope, the presence of blood is confirmed (Li, 2015). Nondestructive tests for blood are used when the sample is limited, and may be performed by
attempting to extract DNA from the presumed blood sample for DNA analysis.
However, if the sample was not blood, DNA would not be extracted and positive results
would not be obtained.
Similar to the testing performed for the indication of blood, colorimetric and
microscopic examinations may be used for presumptive and confirmatory testing when
testing potential body fluid stains for semen. Semen specimens contain high levels of
acid phosphatase. While the acid phosphatase enzyme does appear in semen, it is also
present in nature (Houck & Siegel, 2006). The Brentamine Fast Blue B test is a common
presumptive test employed in semen detection. A purple color formation that follows the
introduction of sodium alpha naphthylphosphate and Fast Blue B solution will indicate
the possible presence of semen (Butler, 2010). To confirm the presence of semen, two
common tests may be performed: direct observation of sperm cells using ‘Christmas
Tree’ staining or prostate specific antigen (PSA)/p30 tests. Direct observation of sperm
cells involves fixing recovered sperm cells on a slide using heat. The cells are then
treated with a ‘Christmas tree’ stain (a reagent that contains aluminum sulfate, nuclear
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fast red, picric acid and indigo carmine). This staining results in red sperm heads, blue
mid pieces of the sperm cells, and yellow-green color tails (Butler, 2012). Forensic
laboratories use observation of the sperm cells under a microscope to confirm the
presence of semen. Multiple tests may be performed to detect the presence of the
PSA/p30 antigen. This antigen is produced in the prostate and secreted into the seminal
fluid. Immunochromatic test kits, similar to home-pregnancy kits or enzyme-linked
immunosorbent assays (ELISA), allow PSA detection (Li, 2015).
The presence of saliva tends to be more difficult to detect in body fluid samples.
Current testing procedures only allow for a presumptive test of saliva; no confirmatory
test is generally used. Presumptive tests for saliva involve testing for amylase. Two
common methods to test for amylase in a sample include the Phadebas test and the starch
iodine radical diffusion test (Butler, 2005). The Phadebas test uses a portion of sample
where saliva is believed to be present (cutting of cloth, swab, etc.) incubated with the
Phadebas reagent. Amylase reacts with the reagent producing a blue color, indicating the
presence of amylase (Li, 2015). The starch iodine test uses an agar gel containing starch.
The sample is placed in a well of the gel, and, if amylase is present, it will diffuse into the
gel, hydrolyzing the starch. The gel is then stained with iodine; clear area in the gel is
indicative of the amylase presence (Li, 2015). While each of these tests may confirm the
presence of amylase, amylase itself may be present in other body fluids than saliva, and,
therefore, these tests will not confirm the presence of saliva (Houck & Siegel, 2006).
Presumptive and confirmatory tests for blood, semen and saliva require different
techniques, different platforms on which to run, and different running times. This creates
a time-consuming process in determining how samples will be processed downstream for
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DNA analysis. Furthermore, the methods described may be destructive to the sample,
and if a limited amount of a sample is present, these tests would not be advised in order
to preserve the sample.
Testing of samples believed to be vaginal fluid or menstrual blood is even more
limited, and requires the use of sample collection and transport to a laboratory. In these
instances, testing of these samples requires microscopic examination or preparation for
immunological assays. These processes are time consuming, labor intensive, costly and
require additional assessment by a trained analyst.
Currently, body fluid tests to indicate vaginal fluid only provide presumptive
results indicating a possible presence. Staining and observation of cells under a
microscope, identification of vaginal acid phosphatase and identification of possible
vaginal bacteria, all work as presumptive tests to indicate the presence of vaginal fluid.
Three cell staining methods: Lugol’s Iodine staining, Periodic Acid-Schiff staining and
Dane’s staining involve introduction of chemical reagents to vaginal epithelial cells fixed
to a microscope slide. Lugol’s will react with glycogenated vaginal epithelial cells to
form a dark brown glycogen-iodine complex, while the periodic acid-Schiff method will
turn the cytoplasm of vaginal epithelial cells magenta and the nucleus purple. The
Dane’s staining method may provide more specificity by staining skin, buccal and
vaginal epithelial cells different colors; red-orange for skin, orange-pink with red nuclei
for buccal and bright orange with orange nuclei for vaginal cells (Li, 2015). Microscopic
observation of the color change in cells is required. Unfortunately, Lugol’s and the acidSchiff methods cannot distinguish between vaginal epithelial cells and other
glycogenated epithelial cells. Further, all three staining techniques may not always
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produce results, therefore false positives or false negatives may occur. Identification of
acid phosphatase may also be important; however, it is necessary to determine if the acid
phosphatase is vaginal or from the prostate due to semen exposure. Vaginal acid
phosphatase (VAP) and prostate acid phosphatase (PAP) are isozymes (enzymes with
similar activities found in different tissues). Agarose gel electrophoresis separates the
two isozymes based on differing electrophoretic mobilities (Li, 2015). The PAP will
travel farther in the gel than the VAP, allowing for vaginal acid phosphatase presence to
be determined. Lastly, testing for bacteria commonly found in vaginal fluid may indicate
its presence. Lactobacillus bacteria are commonly found in the vagina and vaginal
secretions. Testing for multiple Lactobacillus taxa presence may indicate vaginal fluid
however this genus has been seen in semen and female urine so it is not confirmatory (Li,
2015).
Detection of menstrual blood involves the identification of potential degradation
products created during menstruation or enzyme concentrations in the blood. During
menstruation, plasmin cleaves fibrin, known as fibrinolysis, which inhibits the formation
of blood clots. When this occurs, degradation products are formed, specifically D-dimer
which may be detected through enzyme-linked immunosorbent assays (ELISA) or
immunochromatographic assays. Since fibrinolysis occurs during menstruation, these Ddimer assays may positively identify menstrual blood, however D-dimer has also been
found in postmortem blood which, depending on the crime scene, may complicate results
(Li, 2015). Lactate dehydrogenase (LDH) is a common enzyme within the body used
during the process of glycolysis. In blood, five different isoenzymes of LDH; LDH1,
LDH2, LDH3, LDH4 and LDH5, are found. Each of these isoenzymes is capable of
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being separated by their electrophoretic mobility. LDH1, LDH2 and LDH 3 are more
predominantly found in peripheral blood while LDH 4 and LDH 5 are more predominant
in menstrual blood. When blood samples are run on an agarose gel and the enzymes are
separated, the predominant bands may indicate the type of blood from which the sample
came (Li, 2015).
Much research is currently underway to improve upon body fluid identification
methods. Many of these current methods involve the analysis of nucleic acids in the
sample for identification. Messenger RNA (mRNA) expression profiling involves the
identification of mRNA markers that may be used to identify specific body fluids.
mRNA carries the genetic information necessary to make proteins. Identifying specific
mRNA markers for proteins specific to a body fluid type could help in the identification
of that body fluid. Another technique being studied is microRNA (miRNA) profiling.
miRNA profiling involves the identification of specific miRNA markers that will be
unique to a body fluid type. miRNAs are used in the regulation of protein expression so
identification of specific miRNA’s associated with proteins known to be expressed in a
body fluid may lead to the identification of that body fluid. Lastly, DNA methylation
profiling looks at DNA methylation patterns that may be specific to a body fluid type.
Different methylation patterns are tied to the expression of different proteins in body
fluids so this pattern analysis may allow for identification of different body fluid types
(summarized from Harbison & Fleming, 2016).
While each of these techniques has the potential to identify specific body fluids,
they all share some shortcomings. DNA and to a further extent RNA are not the most
stable compounds in an open environment (Frumkin, Wasserstrom, Budowle, &
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Davidson, 2011). Each of these testing methods requires the use of the polymerase chain
reaction (PCR) that requires intact DNA or RNA strands in the region complementary to
primers. The primers are specific to the DNA or RNA sequence in the body fluid type
(Hanson, Lubenow, & Ballantyne, 2009) Partial degradation of DNA or RNA could
inhibit the PCR process, yielding incomplete results. Establishment of these DNA or
RNA assays requires some prior knowledge of the sample in order to determine what
assay kit is required for analysis. If the body fluid type is unknown, the correct assay kit
may not be applied to the correct body fluid type, possibly resulting in inconclusive
results. Extra time would possibly be needed to perform presumptive, and/or
confirmatory tests, prior to analysis. DNA is limited to two copies in the nucleus of the
cell, which limits the amount of total DNA that would be present in a sample. This
potential limit of DNA in the sample could affect how efficient the analysis is in
determining sample type (Li, 2015).
Protein analysis of body fluids by mass spectrometry may provide an alternative
means of identification. Mass spectrometry is used to identify unknown substances based
on the mass of the ions released by the substance after it has been subjected to a
bombardment of energy. When the sample is exposed to the energy source, the sample
becomes ionized, giving the sample a mass-to-charge (m/z) ratio. This ratio is the mass
of the sample over the number of charges on the ion. The ions are then separated in the
spectrometer based on this ratio. When the sample reaches the end of the spectrometer,
the m/z signal is measured based on the time taken to travel through the system and
compared to the signal output. The amino acid sequence of the sample protein is based
on the intensity of the signal over how long the sample traveled in the system. The
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sequence is then compared to a database of known references, and the protein can be
identified (Skoog, Holler, & Crouch, 2007).
There are several types of mass spectrometers used in laboratories and these vary
based on the ionization system or separation system. The matrix-assisted laser
desorption-ionization (MALDI) system introduces the sample into the system evenly
dispersed in a solid or liquid matrix. The sample is placed on a metal plate and a laser
beam is focused on the sample. The matrix absorbs the energy from the laser and
transfers the energy from the matrix to the sample. The sample and matrix are then
desorbed and ionized, releasing an ion plume of both the matrix and the sample. The ion
plume then travels through the analyzer and the spectrum is generated. The typical
separation system used with MALDI ionization is the time-of-flight (TOF) mass
analyzer. In these types of analyzers, the sample ions are separated by drift time. After
the sample is ionized the ions are accelerated through a drift tube, a low-pressure vacuum
sealed tube, where the ions are separated based on mass. The lighter particles travel
faster through the tube and arrive at the detector before the heavier particles (Skoog,
Holler, & Crouch, 2007). The spectrum generated for the sample would then be the m/z
ratio on the x-axis (related to the time of flight) and the intensity of the signal from the
ion on the y-axis.
At the New York City Office of the Chief Medical Examiner (OCME) a
confirmatory body fluid assay using mass spectrometry has been developed for blood,
semen and saliva with testing that aims to expand and include menstrual blood and
vaginal fluid. This assay involves identification of functional proteins unique to each
body fluid that are used as markers to confirm the identity of the body fluid. Samples are
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prepared and proteins are digested overnight into peptide fragments. After the digestion
the samples are plated on a mass spectrometer and the peptides present in the sample are
identified. The identified peptides are then compared to the peptides of known protein
markers and are used to confirm that protein’s presence. Identification of multiple body
fluid marker proteins in the sample may confirm the presence of that body fluid type and
the body fluid may be determined.
Table 1. Components of body fluids used for potential body fluid identification.
Compiled from Virkler & Lednev, 2009, Houck & Siegel, 2006 and Li, 2015.
Blood
Saliva
Semen
Vaginal Fluid
Menstrual Blood
Hemoglobin
Amylase
Acid phosphatase
Acid phosphatase
Blood
Fibrinogen
Lysozyme
Prostate-specific antigen
Lactic acid
Functionalis tissue
Erythrocytes
Mucin
Spermatozoa
Citric acid
Mucus
Albumin
Buccal epithelial cells
Choline
Urea
D-dimer (degradation product)
Glucose
Thiocyanate
Spermine
Vaginal peptidase
Lactate dehydrogenase
Immunoglobulins
Potassium
Semenogelin
Glycogenated epithelial cells
Leukocytes
Bicarbonate
Zinc
Acetic acid
Thrombocytes
Phosphorus
Citric acid
Pyridine
Glucose
Lactic acid
Squalene
Immunoglobulins
Fructose
Immunoglobulins
Urea
Lactobacillus
Ascorbic acid
Immunoglobulins

While the MS assay does present many potential benefits to test for multiple body
fluid types through a single method, there are some steps in the method which may be
improved, thus increasing sensitivity, efficiency and speed. Menstrual blood, vaginal
fluid and other body fluid mixtures are complex samples that need to be further evaluated
to determine better purification steps needed to separate protein markers. Increasing the
sensitivity of the assay will allow for more complex samples to be identified with
confidence through this method. No two cases will provide the same amount of sample,
therefore sample consumption is an issue when performing any test. Evaluating
extraction procedures to have the ability to co-extract protein and DNA samples
simultaneously may save time, money and the limited sample. A co-extraction process

11
may allow for samples to be prepared for DNA analysis, while the body fluid assay
confirms the type of sample being processed. This enables a lab to more efficiently
process the sample. Lastly, the speed with which a sample is able to be processed is
important to prevent any delay in reporting. Current preparation of samples for protein
mass spectrometry involves the digestion of sample proteins overnight with trypsin.
Decreasing the digestion time of samples may increase significantly the speed with which
samples are processed, as well as the quantity of samples that may be processed
simultaneously.
Since the mid 1980’s microwave radiation has been used in organic and inorganic
chemistry as a tool to catalyze reactions. The use of microwaves provides shorter
reaction times, increase yields, and provides a cleaner synthesis by reducing the byproduct of reaction. Since that time the microwaves have proven useful in multiple areas
of science. The mechanism behind how microwaves aid reactions is still not understood
entirely, whether it is purely thermal (heat) based or if it is a combination of thermal and
non-thermal energies. In mass spectrometry proteomic studies, protein digestion is used
to break down proteins into smaller peptide fragments for analysis. The two approaches
for this analysis are “top down” or “bottom up”. The “top down” approach involves
fragmentation of the intact protein sample in a mass analyzer with no previous protein
digestion. The more common “bottom up” approach digests proteins with a proteolytic
enzyme, followed by mass spectrometry analysis. When using the “bottom up”
approach, samples are typically incubated overnight for enzymatic protein digestion. The
overnight digestion is needed for complete hydrolysis of the sample. Research shows
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that the addition of microwave radiation may accelerate proteolysis, sometimes within the
first few minutes of incubation (summarized from Lill, 2009).
This study investigates the use of microwave technology in decreasing the
digestion time of samples and increasing the speed with which samples may be
processed. Studies and research have shown that the use of microwaves may not only
significantly reduce the digestion time of proteins, but also may improve quality in the
analysis of the proteins downstream. Testing of the microwave digestion will be
performed using the current MS protein assay being used. Microwave digestion will be
compared to standard overnight digestion currently in use and assessed for its ability to
reach a complete digestion in a significantly reduced amount of time. Multiple times,
temperatures and power outputs of the microwave will be compared to determine the
ideal microwave specifications to process the samples. The results obtained from this
study show that microwave radiation can be used to aid in protein digestion of protein
markers used in the identification of body fluids, achieving similar results to traditional
protein digestion methods.
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Literature Review
Current research in the identification of body fluids is focused on confirmatory
testing through messenger RNA, microRNA, DNA methylation and mass spectrometry.
Each of these testing methods focuses on the ability to create an ideal assay that would be
able to identify multiple types of body fluids on a single platform. The desire would be
to have an assay that is accurate, reproducible, fast, sensitive, cost efficient and specific
enough to accurately confirm the type of body fluid present. The review below focuses
on different types of nucleic acid body fluid identification methods currently being tested
as well as the mass spectrometry method created by the New York City OCME.
Optimization of the mass spectrometry method is also discussed, specifically the use of
microwaves in the assistance of protein digestion.
Messenger RNA (mRNA) is unique to a cell type, so profiling for specific mRNA
allows analysts to test for mRNAs that may be specific to a body fluid (Butler, 2012).
Research has shown the ability to create a multiplex RT-PCR assay for specific body
fluid genes (Juusola & Ballantyne, 2005). Juusola and Ballantyne presented an assay
specific for eight different body fluids and optimized for blood, saliva, semen and vaginal
secretions. Using the same markers as Juusola and Ballantyne, Haas et al. (2008) found
that testing on samples up to 15 months old were still able to produce positive results for
the different blood types. Research has been conducted on other mRNA markers for the
same body fluids types, and similar results for identification were obtained (Nussbaumer,
Gharehbaghi-Schnell, & Korschineck, 2006). PCR is required in mRNA assays, so
issues pertaining to small amounts of sample or sample degradation may inhibit
amplification in the primer regions (Harbison & Fleming, 2016). Ribonucleases
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(RNases) are also abundant and common to many environments, likewise leading to the
degradation of a sample (Wu & Brewer, 2012).
To overcome possible issues stemming from sample degradation, microRNAs
(miRNAs) have been explored as suitable alternatives. MicroRNAs may be up to ten
times smaller than mRNAs, making them potentially a better option, if degradation is
expected (Zubakov, Boersma, & Choi, 2010). Jung et al. (2010) found that miRNAs
showed better stability than mRNAs in samples where RNA concentration was at least
100 ng/µl. Additionally, it was found that some assays were able to produce positive
results with as little as 50 picograms of total RNA present (Hanson, Lubenow, &
Ballantyne, 2009). The miRNA expression profile for each body fluid obtained by
Hanson et al. was found to be highly specific, and differentiated from the miRNA
expression profiles of 21 other human tissue types. miRNA profiling requires a pattern
of multiple expressed miRNAs for a body fluid type, rather than a single expressed
miRNA (Hanson, Lubenow, & Ballantyne, 2009). For this reason, miRNA studies
typically involve reverse transcription PCR (RT-PCR) and microarray analysis. Zubakov
et al. (2010) was able to confirm miRNA markers with both RT-PCR and microarray
analysis for blood and semen; however, the researchers could not confirm microarray
results of saliva, menstrual blood, or vaginal secretions with RT-PCR. Along with the
multiple assay steps, miRNA profiling requires much care and attention to detail. While
miRNAs tend to show more stability than mRNA, some studies still question the overall
stability of miRNA over time. Bravo et al. (2007) found that samples that were isolated
using a common miRNA kit and stored at -80°C were highly unstable. Further research
into this stability also found that ensuring strict ribonuclease-free storage conditions may
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play a significant role in the stability of miRNA samples (Mraz, Malinova, Mayer, &
Pospisilova, 2009).
DNA is known to be a more stable molecule than RNA, therefore DNA based
assay methods may be more beneficial in identifying body fluid than RNA based
methods. DNA methylation occurs naturally in the human genome; it inhibits gene
expression by affecting chromatin structure (Hashimshony, Zhang, Keshet, Bustin, &
Cedar, 2003). Further, different DNA methylation patterns were found in different
tissues (Li, 2015). These different methylation patterns, tissue-specific differentially
methylated regions (tDMRs), show that body fluids may be distinguished based on these
patterns (An, Choi, Shin, Yang, & Lee, 2013). Frumkin et al. (2011) tested 50 different
samples from blood, semen, saliva and skin and was able to differentiate between them
all. They were further able to demonstrate the identification of semen and saliva
mixtures at different ratios. Other advantages to this technique include the potential to be
easily integrated to existing DNA analysis methods, does not require separate extractions,
and DNA tends to be more stable than RNA (Grskovic, Zrnec, Vickovic, Popovic, &
Mrsic, 2013). While DNA molecules have these advantages, degradation of DNA can
still hinder some of the testing. Age, gender and ethnicity may affect methylation
patterns, and multiple primers would likely still be required to identify different
methylation patters.
Protein analysis of body fluids by mass spectrometry provides an alternative
means for identification of body fluids. Mass spectrometry works by identifying
molecules based on their mass. Samples are ionized through a number of different
methods, and separated based on their mass-to-charge ratio. As the ions travel through a
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spectrometer, a signal is recorded and corelated to a specific molecule. These signals are
compared to known databases, and the molecule being tested may be identified.
Combining a mass spectrometer with liquid chromatography (LC) is beneficial to an
assay since it provides an extra separation step for complex samples (Skoog, Holler, &
Crouch, 2007). In protein mass spectrometry, the LC step helps separate out the peptides
in protein samples after digestion and prior to ionization. Coupling the LC system with a
tandem mass spectrometry system (MS/MS) provides even greater resolution when
identifying peptides in a complex protein sample. In MS/MS systems after the sample is
ionized, it enters a collision chamber where the sample is fragmented. The mass of the
fragments is analyzed, and the parent component is confirmed based on the fragment
masses (Siegel, 2012). Yang et al. (2012) tested five separate methods for the
identification of proteins in menstrual blood. Across all five methods, a total of 1061
menstrual blood proteins were identified. Of those 1061 proteins, 385 were found to be
unique to menstrual blood, while the remaining proteins were shared with venous blood
or vaginal fluid. Each of these methods utilized LC-MALDI TOF/TOF mass
spectrometry for peptide identification. In 2012, a proposal by Dr. Donald Siegel of the
New York City OCME was awarded grant funding from the National Institute of Justice
to further study body fluid protein markers, and establish an assay based on mass
spectrometry. Early results for the mass spectrometry assay were published in 2013 by
Yang et al. In this method, digestion of marker protein present in a body fluid sample
resulted in the different peptide fragments that made up that protein. Tandem mass
spectrometry (MS/MS) analysis allows for the identification of the specific peptides by
comparison to extensive databases. These extensive databases are the result of peptide
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mass fingerprinting - a high throughput method of peptide identification through mass
spectrometry (Henzel, Watanabe, & Stults, 2003). Identification of the peptides is useful
in identifying the presence of a marker protein and the presence of multiple marker
proteins, allowing for the identification of a body fluid. Since mass spectrometry would
identify whatever peptides are present in the sample, prior knowledge of the type of
sample is not necessary. Yang et al. (2013) were able to identify distinct proteins in each
body fluid type: 59 in blood, 48 in semen and 77 in saliva. The number of distinct
peptides that were identified for each body fluid type was 954, 1246 and 922
respectively. Protein markers for each body fluid were selected based on how
unique/enriched the protein was in each body fluid and how abundant the protein was in
the body fluid. This research identified four candidate markers for blood, five for saliva
and eight for semen (Yang, Zhou, Deng, Prinz, & Siegel, 2013).
According to Yang et al. (2013), assay liquid samples were prepared by adding 10
volumes of radioimmunoprecipitation assay (RIPA) buffer to the sample. Samples were
homogenized and spun down. Protein concentration of sample supernatant was measured
using the Bradford Protein assay. Thirty micrograms of total protein were then digested
overnight at 37°C with trypsin in a 20:1 protein to trypsin ratio. Digested peptides from
the samples were separated using high performance liquid chromatography (HPLC).
After the HPLC separation, samples were spotted on a metal plate, and MALDI
TOF/TOF mass spectrometry was performed. Based on the MS/MS sequence obtained,
sample peptides were identified by comparison of the sequence to a database.
One of the draw backs for protein mass spectrometry assays is the amount of time
required for protein digestion. Standard trypsin protein digestions run for long periods,
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anywhere from several hours to overnight (Yu, Gilar, Lee, Bouvier, & Gebler, 2003). The
ability to decrease the amount of time required for a trypsin digestion may reduce
significantly the time required to complete a mass spectrometry assay for the
identification of body fluids. Organic solvents have been used to increase digestion
efficiency and decrease incubation times. Russell and Park (2001) found that addition of
organic solvents increased the amount of digestion fragments recovered after a one-hour
incubation at 37°C versus digestion in an aqueous solvent. The digest fragments from the
aqueous solvent system produced 58% coverage of the entire amino acid sequence in
one-hour, whereas a 60% methanol solution, 40% acetone solution and 40% acetonitrile
solution produced 66%, 79% and 72% coverage of the entire amino acid sequence
respectively (Russell & Park, 2001). Enhanced digestion by means of microwave
radiation has been reported, and yielded significant reductions in digestion time.
Pramanik et al. reported in 2012 the use of microwave radiation to aid tryptic
digestion of bovine cytochrome c. After ten minutes of microwave-assisted digestion, the
authors found a large percentage of peptides that make up the protein by means of mass
spectrometry. Comparison of the microwave to a standard water bath found that a
twelve-minute microwave-assisted digestion at 37°C was comparable to a six-hour
digestion in a water bath at 37°C. Other research has also shown that microwave-assisted
tryptic digestion was much faster, and complete proteolysis could be achieved in onehour, as opposed to water-bath incubated digestion (Lill, Ingle, Liu, Pham, & Sandoval,
2007). Furthermore, research combining the idea of microwave-assisted digestion with
the addition of organic solvents has also showed some promise. Lin et al. (2005) found
that the addition of organic solvents in combination with microwave-assisted digestion
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has the ability to accelerate the enzymatic digestion of some proteins, while decreasing
the time required for digestion, as compared to standard water bath digestions. Research
has also found that in cases where immobilized enzyme is used, as opposed to free
enzyme, more efficient digestion times were achieved with the use of microwave
irradiation (Lin, et al., 2008, A). Here, we examine the effect of microwave radiation in
an effort to decrease the digestion time of proteins of forensically relevant body fluid
samples.
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Material and Methods
Sample Preparation
Blood Samples
All sample tubes were labeled with a sample name and date of preparation. For
samples of a known concentration, the concentration was also recorded on the sample
tube. Venous blood was collected previously and stored by the laboratory in a freezer.
Blood samples were collected during previous research at the New York City OCME in
accordance with approval from the IRB committee at the New York City Department of
Health and Mental Hygiene, IRB 08-040. The blood sample was assigned the unique
identifier “271 Blood”. One-milliliter aliquots from the stock container of 271 blood
were maintained throughout the experiment in 1.5-mL microcentrifuge tubes and kept
frozen. A 1:10 dilution of blood sample was prepared in a 1.5-mL microcentrifuge tube,
50 µl of blood sample in 450 µl of RIPA buffer (Boston Bioproducts Inc., Ashland, MA,
USA).
Hemoglobin Samples
Lyophilized powdered human hemoglobin (Sigma Aldrich, St. Louis, MO, USA)
was stored at 4°C. In a 1.5-mL microcentrifuge tube a solution of hemoglobin was
prepared by dissolving 0.004 g of powder in 1.0 mL RIPA buffer (Boston Bioproducts
Inc., Ashland, MA, USA), yielding a final concentration of 4 µg/µl (wt/v ratio). The
diluted sample was stored at 4°C.
Human Serum Albumin Samples
Human serum albumin powder (Sigma Aldrich, St. Louis, MO, USA) was stored
at 4°C. In a 1.5-mL microcentrifuge tube a solution of human serum albumin was
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prepared by dissolving 0.004 g of powder in 1.0 mL RIPA buffer (Boston Bioproducts
Inc., Ashland, MA, USA), producing a final concentration of 4 µg/µl (wt/v ratio). The
diluted sample was stored at 4°C.
Hemoglobin and Human Serum Albumin Mixture Samples
A volume based one-to-one mixture of 4 µg/µl hemoglobin and 4 µg/µl human
serum albumin was prepared as needed.
Sample Homogenization
All of the samples were homogenized using the FastPrep ®-24 (MP Biomedicals,
Irvine, CA, USA) instrument. To each 1.0-mL microcentrifuge tube-containing sample,
approximately one capful of lysing matrix D beads (MP Biomedicals, Irvine, CA, USA)
was added. The sample was then placed on the FastPrep®-24 (MP Biomedicals, Irvine,
CA, USA) instrument, and vortexed at 6 m/s for 40 seconds. Samples were spun in a
5415 D centrifuge (Eppendorf, Hamburg, Germany) for 1 minute at 8,000 rpm. The
supernatant was transferred to a new 1.5-mL microcentrifuge tube. In a 5810 R
refrigerated centrifuge (Eppendorf, Hamburg, Germany) the homogenized samples were
pelleted by spinning the samples at 18,000 rcf for 30 minutes at 4°C. After the samples
were spun, the supernatant was removed and transferred to a new appropriately labeled
1.5-mL tube for processing. The tube was labeled with a “S” for supernatant. Only
supernatant samples were used for down-stream processing. One-hundred microliters of
RIPA buffer was added to the tube containing the pellet, the tube was vortexed, and the
pellet resuspended. A “P” for pellet was added to the tube label, and the resuspended
pellet sample was stored in a freezer at -20°C.
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Bradford Protein Assay Determines Sample Protein Concentration
For each sample type the Bradford Protein Assay was performed to determine
sample protein concentration. Blood supernatant samples were diluted 1:10 prior to
quantitation; 10 µl of blood supernatant were combined with 90 µl of ddH 2O. A one-toone mixture of hemoglobin and human serum albumin was made. Three-hundred
microliters of hemoglobin supernatant were combined with 300 µl of human serum
albumin supernatant for a total stock volume of 600 µl. Bovine Serum Albumin (BSA) at
a known concentration of 2.0 µg/µl was used as the standard for the assay. A 0.5 µg/µl
dilution of the standard was made by combining 10 µl 2.0 µg/µl BSA (Thermo Scientific,
Waltham, MA, USA) in 30 µl of ddH2O. Dilutions of the concentrated and diluted BSA
were made in a plate to create a range of 0.0 µg/µl to 1.4 µg/µl of the standard. Each of
the standard and sample wells received 250 µl of Bradford reagent. The Bradford reagent
(Coomassie Brilliant Blue) binds to sample protein. As protein concentration increases
the amount of dye bound to the protein increases. Table 2 below shows the concentration
and volumes used for the standards and samples for the assay. Each standard or sample
was processed in duplicate.
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Table 2. Volumes and concentrations of standards and samples used for the Bradford
Protein Assay. The Bovine Serum Albumin (BSA) standard was run at a range of 0.0 µg
to 7.0 µg. Standards and samples were diluted in ddH 2O. Bradford reagent used for all
standards and samples was 250 µl.
Total BSA
(µg)
0.0
0.5
1.0
2.0

BSA
(0.5 µg/µl)
1.0 µl =
0.1 µg/µl
2.0 µl =
0.2 µg/µl
4.0 µl =
0.4 µg/µl

4.0

-

6.0

-

7.0
-

-

BSA
(2.0 µg/µl)
-

Total Water
Volume (µl)
5.0

Total Sample
Volume (µl)
-

Total Bradford
Reagent Volume (µl)
250.0

-

4.0

-

250.0

-

3.0

-

250.0

1.0

-

250.0

3.0

-

250.0

2.0

-

250.0

1.5
5.0
4.0
3.0
2.0
1.0
-

1.0
2.0
3.0
4.0
5.0

250.0
250.0
250.0
250.0
250.0
250.0
250.0

2.0 µl =
0.8 µg/µl
3.0 µl =
1.2 µg/µl
3.5 µl =
1.4 µg/µl
-
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A
B
C
D
E
F
G

1
0.0 µg
BSA
0.5 µg
BSA
1.0 µg
BSA
2.0 µg
BSA
4.0 µg
BSA
6.0 µg
BSA
7.0 µg
BSA

2
0.0 µg
BSA
0.5 µg
BSA
1.0 µg
BSA
2.0 µg
BSA
4.0 µg
BSA
6.0 µg
BSA
7.0 µg
BSA

3
0.0 µl
Sample
1.0 µl
Sample
2.0 µl
Sample
3.0 µl
Sample
4.0 µl
Sample
5.0 µl
Sample

4
0.0 µl
Sample
1.0 µl
Sample
2.0 µl
Sample
3.0 µl
Sample
4.0 µl
Sample
5.0 µl
Sample

5

6

7

8

9

10

11

12

H

Figure 1. Typical plate set up of the Bradford Protein Assay. The first two columns on
the plate contained the standard run in duplicate. Columns containing samples were
paired in twos so the samples could be processed in duplicate. Empty wells on the plate
contained no sample or reagent.
Once the plate was prepared, it was placed on the Synergy HT Multi-detection (Bio-Tek
Instruments, Winooski, VT, USA) to measure the absorbance in each well. Absorbance
was tested at 595 nm, as that is the wavelength of maximum absorbance for Bradford
reagent bound to protein. The average absorbance values for duplicate wells were
determined. Absorption values were corrected to the 0.0 µg/µl standard concentration
value. For example, if the average net absorbance for the 0.0 µg/µl BSA standard was
.470 then .470 was subtracted from the absorbance values of a known concentration.
This subtracted absorbance value was then associated with the known standard
concentration. A standard curve was made in a Microsoft Excel spreadsheet comparing
average absorbance values to known concentrations of the BSA standard. The average
absorbance value of each sample was compared to the standard curve to determine the
concentration of the diluted samples. This concentration was multiplied by the sample
dilution factor to determine the actual concentration of the original sample.
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Preparation of samples for protein digestion
Acetone precipitation, reduction, and cysteine blocking was performed on each
sample prior to protein digestion. Samples were diluted to 1-4 µg/µl, using ddH 2O, based
on the quantitation from the Bradford protein assay. For each digestion condition,
sample tubes, positive controls and negative controls were prepared. A separate tube was
prepared as a comparison control for the traditional overnight digestion. To each tube a
total of 20 µg of sample protein was added. Acetone was chilled to -20°C and samples
were chilled to 4°C. Six volumes of cold acetone were added to each sample and the
control tube. The tubes were inverted three times to ensure homogeneous mixing.
Sample tubes were incubated between 30 minutes and 4 hours (typically 1 hour) at -20°C
until a flocculent formed. Sample tubes were centrifuged for 10 minutes at 6,000 rcf
(Eppendorf, Hamburg, Germany) to pellet the flocculent. Excess acetone was poured off,
and the sample was partially dried at room temperature for 3-5 minutes. After the
acetone precipitation, 20 µl of 500 mM triethylammonium bicarbonate (TEAB) buffer
from the iTRAQ labeling kit (SCIEX, Framingham, MA, USA) was added to resuspend
the pelleted sample. To conserve iTRAQ reagents when samples were not going to be
tested on the LC/MS, 50mM ammonium bicarbonate (ABC) buffer and 50 mM TEAB
buffer (diluted from iTRAQ reagents) were used to resuspend the pellet. The digestion
efficiency during microwave incubation was compared to the 500 mM TEAB buffer.
The 50 mM ABC buffer was prepared by mixing 0.07906 g of ammonium bicarbonate
(Fluka Analytical, St. Louis, MO, USA) in 1.0 mL of ddH 2O for 1M ABC buffer. In a
new tube the buffer was diluted to 50 mM by adding 5 µl of 1M ABC buffer to 95 µl or
ddH2O. Diluted 50 mM TEAB buffer was prepared by combining 20 µl of 500 mM
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TEAB buffer (SCIEX, Framingham, MA, USA) in 180 µl of ddH 2O. After the pellet was
resuspended, 1 µl of denaturant (SCIEX, Framingham, MA, USA) and 2 µl of reducing
reagent (SCIEX, Framingham, MA, USA) were added to each sample. Sample tubes
were vortexed, spun down, and incubated for 1-hour at 60°C. Samples were quick spun
to bring all liquid to the bottom of the tube then 1 µl of cysteine blocking reagent
(SCIEX, Framingham, MA, USA) was added to each sample. To conserve cysteine
blocking reagent for samples not being run on the LC/MS, a solution of 500 mM
iodoacetamide was prepared by combining 0.056 g iodoacetamide (Sigma-Aldrich, St.
Louis, MO, USA) in 600 µl ddH2O. Samples were vortexed and spun to bring all liquid
to the bottom of the tube, then incubated for 10 minutes at room temperature. At this
stage, samples were now prepared for protein digestion.
Traditional protein digestion with trypsin and incubator
A stock solution of 0.5 µg/µl trypsin was prepared by combining 100 µg of
trypsin (Promega, Madison, USA) with 200 µl of trypsin resuspension buffer (Promega,
Madison, WI, USA). Sample tubes were placed on ice prior to trypsin addition to prevent
the reaction from occurring before the samples were placed in a microwave or on an
incubator. To each sample, 2 µl of trypsin was added making the sample protein to
trypsin ratio 20:1. Each positive control tube received 2 µl of trypsin; each negative
control tube received 2 µl of ddH2O in place of trypsin. Samples were vortexed and spun
down, then placed on a tabletop incubator following traditional protein digestion methods
to observe how digestion occurred over different temperatures and times for each sample.
Digestion temperatures of 45°C, 55°C and 65°C were tested and compared to the
traditional digestion temperature of 37°C. Traditional digestion times of 15 minutes, 30
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minutes, 1 hour and 2 hours were compared to the overnight digestion. After each
digestion, phenylmethylsulfonyl fluoride (PMSF) was added to test its ability to inhibit
trypsin activity and allow for better visibility of how each digestion condition worked. A
stock concentration of 100 mM PMSF was prepared by combining 0.017419 g of
phenylmethylsulfonyl fluoride (Acros Organics, Geel, Belgium) with 1.0 mL methanol
(Fisher Scientific, Waltham, MA, USA).
Protein digestion with trypsin and microwave radiation
A stock solution of 0.5 µg/µl trypsin was prepared by combining 100 µg of
trypsin (Promega, Madison, WI, USA) with 200 µl of trypsin resuspension buffer
(Promega, Madison, WI, USA). Samples were placed on ice prior to trypsin addition to
prevent the reaction from occurring before the samples were placed in a microwave or in
an incubator. To each sample 2 µl of trypsin were added, making the sample protein to
trypsin ratio as 20:1. Each positive control tube received 2 µl of trypsin and each negative
control tube received 2 µl of ddH2O in place of trypsin. Samples were vortexed and spun
down. Negative controls were processed in a microwave with samples. Positive controls
were placed in a tabletop incubator at 37°C for the same amount of time as samples were
run in a microwave. A separate overnight tube was also placed inside the tabletop
incubator at 37°C. The microwave used for the experiment was the CEM MARS 6
microwave reaction system (CEM, Matthews, USA). This system allows for adjustment
and regulation of power and temperature control as well as readings of power and
temperature for accurate measurements. Power settings and temperature directly affected
microwave ramp time and run time. Microwave power settings (watts) and temperature
settings (°C) were adjusted to determine ideal power setting to use for consistent ramp
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times. Power settings were adjusted between 50 and 70 watts; temperature settings
ranged from 37°C to 65°C. An ideal power setting of 50 watts was determined to provide
the most consistent ramp time for the varying range of temperatures. Samples are placed
in a hollow microcentrifuge tube container which holds 25 mL of water. The water level
in the container is below the bottom of the tubes so the water never touches the tubes
during the microwave process. The 25 mL water bath captures the microwave energy to
maintain the temperature around the sample tubes. A probe placed into a hole in the cap
of a 1.5 mL microcentrifuge containing buffer continuously monitors the temperature.
Based on the temperature recorded by the probe, microwave input is automatically
adjusted to maintain the desired temperature. Microwave incubation conditions were
tested based on table 3 below. Temperature conditions were tested first followed by run
time. Digestion times were based on the total time samples were in the microwave with
the instrument running. All runs started with an initial 3-minute ramp up to temperature
followed by the remaining time held at that temperature. For example, a 15-minute
digestion would have a 3-minute ramp up to the desired temperature followed by a 12minute hold at the desired temperature. Following each run, samples were placed on ice
and phenylmethylsulfonyl fluoride (PMSF) was added to inhibit trypsin activity and
allow for better visibility of how each digestion condition worked. A stock concentration
of 100 mM PMSF was prepared by combining 0.017419 g of phenylmethylsulfonyl
fluoride (Acros Organics, Geel, Belgium) with 1.0 mL methanol (Fisher Scientific,
Waltham, MA, USA).
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Qualitative Analysis of Samples after traditional and microwave-assisted digestion
A qualitative analysis of the samples was performed using microfluidic gel
electrophoresis (MiGE) on the Agilent 2100 Bioanalyzer (Agilent Technologies, Santa
Clara, CA, USA). For analysis of blood, hemoglobin, human serum albumin and
hemoglobin/human serum albumin mixture samples, the Agilent Protein 80 kit was used.
Based on manufacturer specifications, the Agilent Protein 80 kit has a sizing range of 580 kilo-Daltons (kDa) and is more sensitive for qualitative testing of samples
concentrated between 0.006 – 4.000 µg/µl than other kits. Samples were compared based
on digestion patterns and intermediate digestion products.
Table 3. Example of sample processing to determine ideal microwave digestion
conditions. Negative controls contained sample and all reagents except trypsin. Positive
controls were digested in an incubator to compare similar incubation times between the
microwave and traditional method. An overnight sample was digested in an incubator to
compare the traditional overnight digestion method to the microwave. PMSF was used to
inhibit trypsin digestion after digestion parameters had been reached.
Sample
(In Duplicate)
Negative
0 time
Overnight
Sample 1
Sample 2
Positive

Instrument

Time
(min)

PMSF
(100mM)

Trypsin
(0.005 µg/µl)

Microwave

20

2.9 µl

NA

Temperature
(°C)
37

NA

20

2.9 µl

2.0 µl

37

Incubator

Overnight

2.9 µl

2.0 µl

37

Microwave

20

2.9 µl

2.0 µl

37

Microwave

20

2.9 µl

2.0 µl

37

Incubator

20

2.9 µl

2.0 µl

37
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Results
Bradford Protein Assay
Standard sample concentrations were prepared using the procedure described
previously under the Sample Preparation heading found in the “Methods and Materials”
section. Sample concentrations were determined based on a comparison of absorbance
compared to a known standard of bovine serum albumin (BSA). Standards and unknown
samples were processed in duplicate to determine the mean absorbance value. Mean
absorbance values were corrected to adjust the absorbance value to zero when the sample
concentration was zero. The zero-concentration absorbance was subtracted from the
mean absorbance of each of the samples, and the net absorbance for each sample was
determined. The known concentrations of the BSA standard were compared to the net
absorbance values to create a standard curve. Net sample absorbance values were
compared to the standard curve to determine protein concentration in each of the samples.
271 Blood sample
An initial blood sample was tested as a proof of concept and practice test for lab
familiarization. A standard curve equation was determined based on the known
concentrations of the BSA standard, y = 0.2857x – 0.0121 where y is the net absorbance
and x is the concentration. Net absorbance values for the five diluted samples were
recorded. Using the standard curve equation, concentrations of each diluted sample were
determined. Table 4 below shows the absorbance, net absorbance and concentration
values for the BSA standard and diluted blood sample 271.
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Table 4. Absorbance, mean absorbance, net absorbance and concentration of known
BSA standards and 271 blood sample.
Bradford BSA Standard
Conc.
(µg/µl)

Abs. 1

0.0
0.1

0.471
0.499

0.2
0.4

Bradford 271 Blood Sample
Abs. 2

Mean
Abs.

Net
Abs.

Conc. based on
STD curve (µg/µl)
y=0.2857x-0.0121

0.468
0.585

0.469
0.591

0.000
0.122

0.469

0.744
0.876

0.727
0.855

0.736
0.866

0.267
0.397

0.977
1.432

0.961
1.032

0.962
1.047

0.962
1.040

0.493
0.571

1.768
2.041

Abs. 2

Mean
Abs.

Net
Abs.

Sample
Vol. (µl)

Abs. 1

0.470
0.508

0.471
0.504

0.000
0.033

0.000
1.000

0.469
0.596

0.529
0.543

0.517
0.475

0.523
0.509

0.053
0.039

2.000
3.000

0.8
1.2

0.731
0.826

0.696
0.779

0.714
0.803

0.243
0.332

4.000
5.000

1.4

0.866

0.850

0.858

0.388

Net Absorbance (595 nm)

BSA Standard Curve for 271 Blood Sample Concentration
0.450
0.400
0.350
0.300
0.250
0.200
0.150
0.100
0.050
0.000
-0.050

y = 0.2857x - 0.0121
R² = 0.9665

BSA
BSA Standard Curve

0.0

0.2

0.4

0.6

0.8

1.0

1.2

1.4

1.6

Concentration (ug/ul)

Figure 2. Standard curve of known BSA standard concentrations to determine unknown
concentrations of 271 blood sample.

To estimate the whole blood sample concentration, known concentrations of diluted
blood samples were multiplied by dilution factors. Table 5 below shows the dilution
factor of each sample run on the Bradford assay, the concentration of each sample after it
was multiplied by its dilution factor and the average concentration of the original sample
used for the Bradford assay.
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Table 5. Estimated concentration of 271 blood sample prior to Bradford Assay
Diluted 271 Blood Supernatant Concentration
Sample Vol. (µl)
1.000
2.000
3.000
4.000

Conc. based on STD curve (µg/µl)
0.469
0.977
1.432
1.768

5.000

2.041

Bradford Assay Dil. Factor
5.000
2.500
1.667
1.250

Conc. Before Bradford
2.347
2.442
2.387
2.210

1.000

2.041

Avg. Conc.

2.285

The concentration of each sample was multiplied by its dilution factor from the assay and
then the average concentration was determined. The average concentration was
multiplied by 100 to account for the two 10 X dilutions performed before the assay. The
final estimated concentration of blood sample 271 was 228.5 µg/µl.
271-Blood and Hemoglobin-HSA mixture samples
Samples of 271 Blood and Hemoglobin-HSA mixture were tested using the
Bradford protein assay to determine the concentration of diluted blood samples and
freshly mixed hemoglobin-HSA samples to be used for protein digestion testing.
Samples were prepared as previously described under the Sample Preparation heading of
the Methods and Materials section of this paper. Blood samples were diluted 100 times
while the fresh hemoglobin and HSA samples were made stock at approximately 4 µg/µl
with hemoglobin human lyophilized powder and human serum albumin powder
respectively. Three-hundred microliters of stock hemoglobin and HSA were combined
for a total of 600 µl of approximately 4.0 µg/µl hemoglobin-HSA mix. A standard curve
equation was determined based on the known concentrations of the BSA standard, y =
0.3535x – 0.0316 where y is the net absorbance and x is the concentration. Net
absorbance values for the five diluted samples were recorded. Using the standard curve
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equation, concentrations of each sample were determined. Tables 6, 7 and 8 below show
the absorbance, net absorbance and concentration values for the BSA standard, diluted
271 blood sample, and hemoglobin-HSA mix sample respectively.
Table 6. Absorbance, mean absorbance, net absorbance and concentration of known
BSA standards.
Conc. (µg/µl)
0.0
0.1
0.2
0.4
0.8
1.2
1.4

BSA Standard
Abs. 1 Abs. 2 Mean Abs.
0.399
0.395
0.397
0.408
0.410
0.409
0.432
0.424
0.428
0.474
0.463
0.469
0.647
0.629
0.638
0.819
0.750
0.785
0.868
0.896
0.882

Net Abs.
0.000
0.012
0.031
0.072
0.241
0.388
0.485

Table 7. Absorbance, mean absorbance, net absorbance and concentration of 271 Blood
sample.
271 Blood Sample
Sample Vol. (µl)
0.000
1.000
2.000
3.000
4.000
5.000

Abs. 1
0.403
0.545
0.704
0.701
0.926
0.988

Abs. 2
0.407
0.537
0.689
0.851
0.916
0.973

Mean Abs.
0.405
0.541
0.697
0.776
0.921
0.981

Net Abs.
0.000
0.136
0.292
0.371
0.516
0.576

Conc. based on STD curve (µg/µl)
y = 0.3535x – 0.0316
0.474
0.914
1.139
1.549
1.717

Table 8. Absorbance, mean absorbance, net absorbance and concentration of
hemoglobin-HSA mixture sample.

Sample Vol. (µl)
0.000
1.000
2.000
3.000
4.000
5.000

Abs. 1
0.395
1.152
0.986
1.209
1.301
1.469

Abs. 2
0.408
0.933
0.998
1.173
1.345
1.482

Hemoglobin-HSA Mixture Sample
Conc. based on STD curve (µg/µl)
Mean Abs.
Net Abs.
y = 0.3535x – 0.0316
0.402
0.000
0.933
0.532
1.593
0.992
0.591
1.760
1.191
0.790
2.323
1.323
0.922
2.696
1.476
1.074
3.128
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In table 8, the absorbance value recorded for the first absorbance for sample volume 1.0
of the hemoglobin-HSA mixture was not used for the mean absorbance value or net
absorbance value. This value was believed to be an outlier and had no significant effect
on the actual undiluted sample concentration. Figure 3 shows the standard curve used to
determine the concentration of each sample.

BSA Standard Curve for 271 Blood and Hemo-HSA Sample
Concentration
0.600

Net Absorbance (595 nm)

0.500

y = 0.3535x - 0.0316
R² = 0.9863

0.400
0.300
BSA
0.200

BSA Standard Curve

0.100
0.000
0.0
-0.100

0.2

0.4

0.6

0.8

1.0

1.2

1.4

1.6

Concentration (ug/ul)

Figure 3. Standard curve of known BSA standard concentrations to determine unknown
concentrations of 271 blood sample and hemoglobin-HSA mixture sample.
During testing a second stock of the hemoglobin-HSA mixture sample was prepared.
This stock was prepared as described above and tables 9 and 10 show the absorbance, net
absorbance and concentration values for the BSA standard and second hemoglobin-HSA
mix sample. Figure 4 shows the standard curve used to determine the concentrations.
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Table 9. Absorbance, mean absorbance, net absorbance and concentration of known
BSA standards.
Conc. (µg/µl)
0.0
0.1
0.2
0.4
0.8
1.2
1.4

BSA Standard
Abs. 1 Abs. 2 Mean Abs.
0.487
0.484
0.486
0.514
0.514
0.514
0.536
0.533
0.5345
0.569
0.601
0.585
0.710
0.725
0.718
0.821
0.801
0.811
0.870
0.903
0.8865

Net Abs.
0.000
0.029
0.049
0.100
0.232
0.326
0.401

Table 10. Absorbance, mean absorbance, net absorbance and concentration of
hemoglobin-HSA mixture sample.

Sample Vol.(µl)
0.000
1.000
2.000
3.000
4.000
5.000

Hemoglobin-HSA Mix Sample
Conc. based on STD curve (µg/µl)
Abs. 2 Mean Abs. Net Abs.
y=0.284x-0.0041
0.490
0.490
0.000
0.650
0.646
0.156
0.564
0.734
0.752
0.262
0.935
0.861
0.864
0.374
1.330
0.991
0.970
0.480
1.703
1.187
1.111
0.621
2.199

Abs. 1
0.490
0.642
0.769
0.866
0.948
1.034

Net Absorbance (595 nm)

BSA Standard Curve for Hemoglobin-HSA
Sample Concentration
0.450
0.400
0.350
0.300
0.250
0.200
0.150
0.100
0.050
0.000
-0.050

y = 0.284x - 0.0041
R² = 0.9973

BSA
BSA Standard Curve

0.0

0.2

0.4

0.6

0.8

1.0

1.2

1.4

1.6

Concentration (ug/ul)

Figure 4. Standard curve of known BSA standard concentrations to determine unknown
concentration of hemoglobin-HSA mixture sample.
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A standard curve equation was determined based on the known concentrations of the
BSA standard, y = 0.284x – 0.0041 where y is the net absorbance and x is the
concentration. Net absorbance values for the five diluted samples were recorded. Using
the standard curve equation, concentrations of each sample were determined.
Concentrations of the undiluted supernatant sample (sample volume = 5.0 µl) were used
when determining the amount of sample to add to downstream protein digestion testing.
The concentration of the 271 blood supernatant sample used for protein digestion testing
was 1.717 µg/µl. The concentrations of the hemoglobin-HSA samples used for protein
digestion testing was either 3.128 µg/µl or 2.199 µg/µl.
Agilent Bioanalyzer Assay Familiarization
Based on manufacturer specifications, the Agilent Protein 80 kit has a sizing
range of 5-80 kDa and is more sensitive for qualitative testing of samples concentrated
between 0.006 – 4.000 µg/µl than the Agilent Protein 230 kit. For this reason, the
Agilent Protein 230 kit was used for lab familiarization and the Agilent Protein 80 kit
was used for any samples where protein digestion was performed. Blood supernatant
samples were run diluted and neat on the Agilent Protein 230 kit. In figure 5 a gel image
of neat and diluted blood supernatant samples is shown. Based on band intensity, lanes 1
through 6 qualitatively show a decrease in the amount of protein present in the blood
sample from 1.0 µg/µl to 0.2 µg/µl.
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Figure 5. Gel image of a bioanalyzer run qualitatively showing the decrease in the
concentration of protein present in blood samples. Protein concentrations were measured
in kilo-Daltons (kDa).
PMSF time 0 establishment
A trial run of freshly prepared PMSF compared to older stock PMSF was
performed to evaluate the quenching ability of fresh versus old PMSF as well as establish
a “time 0” bioanalyzer run to compare samples where trypsin and PMSF were added.
Figure 6 shows the comparison of trial runs between freshly made and old PMSF. The
multiple bands in all sample wells where PMSF was added after trypsin show that trypsin
digestion began to immediately occur with the addition of trypsin. After PMSF was
added digestion stopped, however there would always be some digestion that occurred
versus samples where no trypsin was added.
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Figure 6. Comparison of freshly made PMSF versus old PMSF to establish “time 0” for
trypsin digestions.
Based on band intensity the freshly made PMSF showed stronger band intensity at
approximately 11.0 kDa compared to the old PMSF. The old PMSF had stronger band
intensity at approximately 5.0 kDa. This indicates at time 0 more digestion occurred
using old PMSF to quench the digestion as compared to freshly made PMSF. The figure
also shows that when no trypsin was added to samples no digestion occurred. Table 11
shows the different peak sizes seen at time 0 for fresh and old PMSF. Electropherograms
of each bioanalyzer run were used to compare the size of the digested protein for each
sample (based on peak size in electropherogram, visualized as a band on the gel). An
example electropherogram can be referenced in the appendix (Figure 18). These multiple
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peak ranges will be used to compare different digestion conditions where PMSF is used
to quench the digestion after a specified amount of time.
Table 11. Peak size of visible bands seen in time 0 comparison of freshly made versus old
PMSF.

No Trypsin/No PMSF 1
Fresh PMSF 1
Fresh PMSF 2
Fresh PMSF 3
Fresh PMSF 4
Old PMSF 1
Old PMSF 2
No Trypsin/Fresh PMSF 1
No Trypsin/Fresh PMSF 2
No Trypsin/No PMSF 2

Peak 1
11.5
5.1
5.3
5.0
5.2
5.1
5.4
11.7
11.7
11.8

Peak 2

Peak Size (kDa)
Peak 3 Peak 4

5.5
6.1
5.3
5.9
5.9
6.2

5.9
6.7
5.7
6.4
6.3
7.1

6.3
8.9
6.1
8.3
7.7
9.5

Peak 5

Peak 6

8.1
11.1
7.2
10.3
9.9
11.7

10.1
9.1

Traditional protein digestion at different temperatures
Comparison of varying digestion temperatures using the traditional digestion
method were tested to determine digestion efficiency. These digestions were used as a
baseline of the traditional digestion to compare to microwave digestion methods under
similar conditions. Temperature conditions tested were 45°C, 55°C and 65°C.
Incubation was performed on a table top incubator for 15-minutes. A positive control
which doubled as the current traditional method comparison was run at 37°C on a
separate table top incubator. Negative controls were processed with the sample and all
reagents excluding trypsin. Figure 7 shows the bioanalyzer results for the 45°C and 55°C
trials. Figure 8 shows the results for the 65°C trial. Each bioanalyzer gel image
indicates, as incubation temperature increased, digestion efficiency decreased. Digestion
efficiency was determined by the number of intermediate digestion products present as
well as the intensity of the intermediate digestion product bands. More intermediate
product bands and more intense bands indicate less efficient digestion. Comparing these
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digests to the traditional incubation digest indicates at 45°C, digestion was similar to but
not as efficient as the digestion at 37°C. Band intensity of the second larger fragment
peak was stronger for samples incubated at 45°C than it was at 37°C. This indicated a
higher concentration of intermediate digestion product at that fragment size for the 45°C
samples and slightly less efficient digestion. Multiple peak bands were seen in the 55°C
run. The bands seen in this run are similar to the ones seen for the PMSF time 0 trials
indicating some digestion occurred but the digestion was not very efficient. The
strongest band present at the 55°C incubation was the largest peak (12.9 kDa) indicating
minimal digestion. Multiple bands were present in the 65°C run however the most
intense band by far was the largest band (12.9 kDa). The intensity of this band was most
similar to the negative control indicating the least effective digestion at this temperature.
Sample 6 (lane 4 on the gel image) had a large dip below the baseline in the
electropherogram due to an error during the run. The electropherogram can be referenced
in the appendix (Figure 19). Results and peak sizes from this sample will not be as
accurate due this anomaly however it can still be clearly seen that this sample also
exhibited poor digestion.
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Figure 7. Traditional protein digestion on incubator at 45°C and 55°C compared to
digestion at 37°C.
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Figure 8. Traditional protein digestion on incubator at 65°C compared to digestion at
37°C.
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Table 12 lists the peak bands seen at each temperature condition. More peak bands
indicate less efficient digestion for those temperatures. Temperatures of 37°C and 45°C
where the undigested sample peak band (12.9 kDa) is completely gone indicate a more
efficient digestion.
Table 12. Peak sizes seen for each temperature digestion condition.

Positive Control 1, 37°C
Positive Control 2, 37°C
Sample 1, 45°C
Sample 2, 45°C
Negative Control 1, 45°C
Negative Control 2, 45°C
Sample 3, 55°C
Sample 4, 55°C
Negative Control 3, 55°C
Negative Control 4, 55°C
Positive Control 3, 37°C
Positive Control 4, 37°C
Sample 5, 65°C
Sample 6, 65°C
Negative Control 5, 65°C
Negative Control 6, 65°C

Peak 1
5.3
5.8
5.8
5.8
12.8
12.8
5.7
6.1
12.9
12.9
5
5.7
6.1
4.9
12.9
12.8

Peak 2
6.7
7.9
7.8
8

Peak Size (kDa)
Peak 3 Peak 4

Peak 5

Peak 6

Peak 7

12.9

6.1
6.6

6.6
7.9

7.9
9.3

9.2
11.2

11.1
12.9

6.2
7.6
6.5
5.5

7.9
6.3

9.3
7.8

11.2
10

12.9

Traditional sample protein digestion at different times
Blood samples and hemoglobin-human serum albumin (HSA) mixture samples
were digested following traditional protein digestion procedures on an incubator at 37°C.
Gel images were captured on the Agilent 2100 Bioanalyzer using the Agilent Protein 80
kit. Digestion times of 15-minutes, 30-minutes, 1-hour, 2-hours and overnight were
compared. Figures 9 and 10 show the gel image for comparison of each time trial for
blood and hemoglobin-HSA samples. Gel images for individual runs of 30-minutes, 1hour, 2-hours and overnight digestions for each sample can be found in the appendix
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(Figures 20-27). The longer the digestion time the less intense the protein band. Color
intensity of the bands on the gel image indicate the concentration of protein present at
that size. Higher intensity bands indicate a higher concentration of protein at that size
and lower intensity bands indicate a lower concentration of protein. For the blood sample
a single band at approximately 12.5 kilo-Daltons (kDa) is visible in all lanes where no
trypsin digestion was performed. This band likely represents the protein hemoglobin
found in blood samples. Lanes 2 and 8 show the time 0 comparison when trypsin was
added to the sample followed immediately by PMSF to quench the digestion. It can be
seen that some digestion did occur at time 0. In all lanes where trypsin digestion took
place the 12.5 kDa band is no longer present and there is an intermediate band at
approximately 5.5 kDa, showing digestion of the larger protein into smaller fragments.
The band intensity at the 5.5 kDa band is similar for the 15-minute, 1-hour and 2-hour
runs. The band is significantly more intense for the 30-minute run but less intense for the
overnight run. It can be seen that generally the intensity of the 5.5 kDa band decreased
over time. The increase in band intensity at approximately 3.5 kDa also suggests some of
the protein from the sample was digested further to the smaller 3.5 kDa fragments. This
band also showed a decrease in intensity for the overnight digestion.
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Figure 9. Comparison of traditional trypsin protein digestion of blood sample for 15minutes, 30-minutes, 1-hour, 2-hours and overnight.
For the hemoglobin-HSA mixture samples where no trypsin digestion took place, two
main bands were seen, one at approximately 63.3 kDa and one at approximately 12.4
kDa. The 63.3 kDa band represents the human serum albumin protein and the 12.4 kDa
band represents the hemoglobin protein. Lane 2 shows the time 0 comparison when
trypsin was added to the sample followed immediately by PMSF to quench the digestion.
It can be seen that some digestion did occur at time 0. In all lanes where trypsin
digestion took place the 63.3 kDa and 12.4 kDa bands are no longer present and are
replaced by bands between 4.1 kDa and 7.6 kDa depending on the sample. These bands
represent intermediate digestion products that have not been fully digested by the trypsin.
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The 30-minute, 1-hour and 2-hour digestion samples show bands at 4.9 and 7.6 kDa, 4.9
and 7.5 kDa, and 4.1 and 5.9 kDa respectively. The 15-minute digestion shows a single
band at 5.8 kDa however this is not believed to be a true representation of the digestion.
The overnight digest shows a nearly non-existent band at 4.1 kDa. None of the samples
showed any bands near the 63.3 kDa range. Treating the 15-minute digestion sample as
an outlier, based on band intensity, it appears that as digestion time increased with these
samples, overall protein digestion increased. Based on the change in intensity of the band
at 3.5 kDa it suggests further digested protein fragments at that smaller intermediate
digestion product size were also seen in these samples.

Figure 10. Comparison of traditional trypsin protein digestion of hemoglobin-HSA
sample for 15-minutes, 30-minutes, 1-hour, 2-hours and overnight.
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Comparison of microwave incubation at different temperatures and times
Microwave assisted protein digestion was compared at different microwave
incubation temperatures and times. Microwave temperature samples were compared to
positive control samples digested on a table top incubator at 37°C. Temperature
digestions of 37°C, 45°C, 55°C and 65°C were performed for 15-minutes. Microwave
digestions included a 3-minute ramp up to temperature and a 12-minute digestion while
positive controls were on an incubator for the full 15-minutes. Figures 11 through 14 are
the bioanalyzer runs for microwave digestions at 37°C, 45°C, 55°C and 65°C
respectively. The 37°C run showed the most comparable results to the 37°C positive
control. Both samples had complete digestion of the 12.7 kDa sample protein. Two
smaller protein fragments between 7.8 kDa and 5.3 kDa were seen in both the microwave
sample and positive control sample. Band intensity was also stronger for these samples
around the 5.3 kDa peak and the less intense band around 7.8 kDa. Both 37°C
microwave samples and positive controls showed increased band intensity at the 3.5 kDa
bioanalyzer system peak as well. These peaks and intensities all indicate similar
digestion efficiency between the microwave and 37°C and traditional incubator digestion
at 37°C.
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Figure 11. Comparison of the microwave incubation at 37°C versus traditional incubator
incubation at 37°C.
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Figure 12. Comparison of the microwave incubation at 45°C versus traditional incubator
incubation at 37°C.
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Figure 13. Comparison of the microwave incubation at 55°C versus traditional incubator
incubation at 37°C.
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Figure 14. Comparison of the microwave incubation at 65°C versus traditional incubator
incubation at 37°C.
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Microwave digestions at 45°C, 55°C and 65°C all had more than two peak bands present
between approximately 5.7 kDa and 12.9 kDa. Multiple bands (more than two) for each
of these temperature conditions and the presence of the 12.9 kDa band indicate a less
efficient protein digestion at the higher temperatures. Intensity of the 3.5 kDa band was
also less intense than seen in the 37°C positive control or 37°C microwave sample
providing more evidence to a less efficient digestion. Table 13 shows all of the peak
sizes seen for each temperature digestion condition. For the 65°C run trypsin was
accidentally added to all negative controls so there is no standard to compare where
trypsin was not added for that run. However, it should be noted that the less efficient
digestion at 65°C is still indicated by the multiple peak bands seen. Based on these
results ideal microwave digestion temperature was determined to be 37°C.
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Table 13. Peak band sizes seen for microwave digestions of 37°C, 45°C, 55°C and 65°C.
37°C
5.3
6.6
Microwave Sample 1

5.4
7.0

5.8
6.0
7.8
9.1
11.0
12.8
5.7
7.9
9.1
11.1
12.8

6.2
8.4
9.6
11.5
13.1

5.7
7.8
5.7
7.7

5.6

6.3

5.4
6.9

12.7

12.8

6.0
8.2
9.8
12.9

12.7

12.8

12.8

12.8

12.7

12.7

12.7

12.7

12.8

Microwave Sample 2

5.7
7.8
Microwave Sample 3

Pos. Control 1
Pos. Control 2

Peak Size (kDa)
45°C
55°C
5.7
6.1
7.8
8.2
9.0
9.4
11.1
11.2
12.6
12.8

6.3
8.1
9.5
11.4
12.9

Neg. Control MCRW 1

Neg. Control MCRW 2

Neg. Control Frz. 1

Neg. Control Frz. 2

65°C
6.1
6.5
7.9
9.1
11.0
12.5
6.1
8.0
9.2
11.1
12.7
5.8
6.5
7.8
9.1
11.0
12.6
5.5
5.7

5.8
6.1
6.5
7.9
9.2
11.1
12.7
6.0
6.5
7.8
9.1
11.0
12.6
6.0
7.8
9.0
10.7
12.4
6.1
8.0
9.4
11.2
12.8
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Microwave digestion times of 15-minutes, 30-minutes, 1-hour and 2-hours were
compared. Digestions were performed at 37°C based on the results of the previous
temperature test. Microwave digestion times of 5-minutes and 10-minutes were also
performed; see appendix (Figures 28 and 29). It was determined these digestion times
were two short and were not considered to test ideal digestion time. All microwave
digestions included a 3-minute ramp up to temperature with the remaining time being
used for the digestion (i.e. 30-minute digest = 3-minute ramp, 27-minute digest). Figure
15 shows the 15-minute and 1-hour microwave digestions compared to the digestions of
the same time on a table top incubator. Figure 16 shows the 30-minute and 2-hour
microwave digestions compared to the digestions of the same time on a table top
incubator. A sample was digested overnight following the traditional procedure and run
on the bioanalyzer with the 15-minute and 1-hour run.
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Figure 15. 15-minute and 1-hour microwave digestion compared to incubator digestion.
Traditional overnight sample digestion added for comparison.

56

Figure 16. 30-minute and 2-hour microwave digestion compared to incubator digestion.
As can be seen in the above figures, all samples incubated in the microwave showed
digestion of the 12.9 kDa band. A single band at approximately 5.5 kDa was seen in each
time trial indicating digestion of the 12.9 kDa band had occurred but not to completion.
As the length of digestion increased from 15-minutes to 2-hours the intensity of the 5.5
kDa band decreased. This indicates as the sample digestion incubated longer more
digestion occurred. Comparison of the microwave samples to the sample incubated on
the table top incubator showed similar band intensities at 5.5 kDa indicating the
microwave and incubator had similar digestion efficiencies. No peak band intensity of
the overnight sample was seen at 5.5 kDa indicating complete digestion of the 12.9 kDa
band from incubating overnight. Based on these results increased digestion time in the
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microwave showed comparable digestion to the incubator however complete digestion
was not achieved as was seen in the overnight incubation.
Comparison of buffers during microwave incubation
Three different buffers were compared to test the effect of each on protein
digestion. This was done in an attempt to conserve reagents when samples were not
planned to be processed on a mass spectrometry instrument. Samples that would
typically be processed on a mass spectrometry instrument use 20 µl of 500mM TEAB
buffer. A 50mM dilution of 500mM TEAB buffer and 50mM ABC buffer were
compared to the original 500mM TEAB buffer. All protein samples tested came from
blood sample 271 following the digestion protocol described in the Methods and
Materials section. Figure 17 is a gel image comparing the three buffers. Samples in
lanes 1, 4 and 7 were digested using the CEM MARS 6 microwave at 37°C for 15minutes. Samples in lanes 2, 5 and 8 were used as positive controls to test the digestion
on a traditional incubator at 37°C for 15-minutes. Samples in lanes 3, 6 and 9 were used
as negative controls, they were incubated at 37°C in the CEM MARS 6 microwave for
15-minutes and no trypsin was added to the sample.
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Figure 17. Comparison of digestion efficiency of three different buffers in the MARS 6
microwave and traditional incubator.
As can be seen in figure 17 the 500mM and 50mM TEAB buffer appear to show better
protein digestion efficiency after 15-minutes than the 50mM ABC buffer. In the lanes
with TEAB buffer, both the microwave and traditional incubator digestion showed the
large protein band at approximately 12.5 kDa seen in each negative control is no longer
present and an intermediate digestion product band at approximately 5.6 kDa is now
present. In the ABC buffer two distinct bands can be seen in the microwave and
incubator lanes; one at approximately 5.9 kDa and one at approximately 8.5 kDa
indicating the digestion was not as efficient as the TEAB buffer. Table 14 below shows
the size of each protein band based on the buffer used for digestion.
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Table 14. Peak size of digested and undigested samples.
Sample Peak Size

TEAB 500mM
TEAB 500mM POS
TEAB 500mM NEG
TEAB 50mM
TEAB 50mM POS
TEAB 50mM NEG
ABC 50mM
ABC 50mM POS
ABC 50mM NEG

Peak Size
(kDa)
5.4
5.6
12.6
5.7
5.7
12.5
5.9
6.0
12.6

Peak Size
(kDa)

8.2
8.5

Based on the size of the peaks seen, all three buffers performed similarly. The TEAB
buffer at 500mM showed protein bands at 5.4 kDa (microwave) and 5.6 kDa (incubator)
while the TEAB buffer at 50mM showed protein bands at 5.7 kDa for both the
microwave and incubator. The ABC buffer showed slightly larger protein bands at 5.9
kDa (microwave) and 6.0 kDa (incubator) as well as a secondary band at 8.2 kDa
(microwave) and 8.5 kDa (incubator). The larger bands in the ABC buffer as well as the
secondary band indicate the TEAB buffer at either concentration was slightly more
efficient in aiding protein digestion than the ABC buffer. This allowed for use of a
diluted concentration of TEAB buffer for samples not being processed on the mass
spectrometry instrument to conserve reagents.
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Discussion
Bradford Protein Assay Sample Concentrations
To familiarize with lab practice, the protein concentrations of blood samples were
determined using the Bradford Protein Assay. A range of known concentrations of
bovine serum albumin (BSA) was prepared along with a range of dilutions of the
unknown blood samples. Fluorescence of the BSA dilutions was measured and a
standard curve using the known concentrations was prepared. Fluorescence of the
unknown sample dilutions was then compared to the standard curve. Concentrations
were multiplied by the dilution factor obtained from sample preparation. The average of
these concentrations was determined and the concentration of each prepared sample was
estimated. Neat sample protein concentrations for blood were estimated by multiplying
the prepared sample concentrations by the dilution factor prior to sample
homogenization. Neat blood protein concentrations were estimated to be 228.5 µg/µl.
Expected sample concentrations of blood were approximately 150.0 µg/µl. Variation
between actual concentrations observed and expected concentrations can be attributed to
sample preparation method in which large dilutions of each sample were made. The
Bradford Assay tests were performed to help familiarize with sample preparation,
dilution and protein concentration so samples could properly be prepared for protein
digestions. These samples were not used during protein digestion.
Blood samples and hemoglobin-HSA samples were prepared and concentrations
of diluted samples were determined using the Bradford Protein Assay. Two different sets
of hemoglobin/HSA mixture samples were prepared. Comparison to the standard curve
showed the diluted blood samples to have an approximate concentration of 1.717 µg/µl
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while the hemoglobin-HSA mixture samples had an approximate concentration of 3.128
µg/µl and 2.199 µg/µl. These known concentrations were used to determine the volume
of sample added for each protein digestion. Total sample protein in a digestion was
approximately 20 µg. Two microliters of 0.5 µg/µl trypsin was added to each digestion
so the protein to trypsin ratio was 20:1. Protein to trypsin ratio was determined from
previous testing for body fluid identification by mass spectrometry (Yang, Zhou, Deng,
Prinz, & Siegel, 2013). This protein to trypsin ratio appeared to show efficient digestion
ability for the examined digestion parameters. Protein digestion was visualized on the
Agilent 2100 Bioanalyzer. A gel image was generated based on electropherogram peaks
observed after microfluidic gel electrophoresis (MiGE). Protein samples were added to
the microfluidic chip and, with the help of an electric current, passed through a small
column. The larger the protein size the longer it would take to pass through the column.
In the column the protein sample binds to a fluorescent dye. When the fluorescent bound
protein sample nears the end of the column a laser excites the dye and a fluorescent signal
is released. This signal is recorded on an electropherogram. The sizing ladder marks
known protein sizes based on the time traveled through the column. By comparing the
sample to the ladder, the size of the sample protein is determined based on the time it
took to pass through the column. The amount of protein present in the sample is based on
the intensity of the fluorescent signal released after the sample is excited with a laser.
The intensity of the bands correlate to the peak height in the electropherogram. The more
protein in the sample, the more fluorescence the sample will give after laser excitation,
the more intense the band on the gel, and the taller the peak in the electropherogram.
Figure 18 in the appendix provides an example of an electropherogram where the peaks
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on the electropherogram can be visualized in a gel image. Figure 5 shows how the
protein bands in neat and diluted blood samples are visualized on the gel image. Based
on band intensity, lanes 1 through 6 qualitatively show a decrease in the amount of
protein present in the blood sample from 1.0 µg/µl to 0.2 µg/µl. The decrease in intensity
is expected because the amount of protein in the sample was decreased.
PMSF time 0 establishment
Phenylmethylsulfonyl fluoride (PMSF) was used to quench the trypsin digestion.
This was done to stop any trypsin digestion from continuing after samples were removed
from the incubation source. This allowed for more accurate evaluation of the time and
temperature trials in regards to how efficient protein digestion was for the conditions
tested. PMSF was chosen as the quenching mechanism for the trypsin digestion based on
its high inhibitor activity. Garcia-Carreno (1993) showed PMSF inhibited trypsin at
96%, suggesting once samples were removed from the incubation step and PMSF added,
minimal digestion would continue to take place. A boiling method was also considered
to quench digestion (Petritis, Qian, Camp II, & Smith, 2009), however this method
involved liquid nitrogen freezing after boiling of the sample and seemed more difficult to
perform. Time 0 digestion was established by adding trypsin to the sample directly
followed by PMSF so the PMSF would immediately stop the digestion. Bioanalyzer
results show that upon the addition of trypsin, even when PMSF is added to the sample
first, some digestion still takes place. This can be attributed to the fact that while PMSF
does inhibit trypsin digestion, the inhibition is not complete. The time 0 PMSF trial also
compared the use of freshly made 10mM PMSF compared to week old stock 10mM
PMSF. Fresh PMSF showed a similar digestion pattern to old PMSF with one exception.
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Based on the intensity of the digestion bands seen in the bioanalyzer image, freshly made
PMSF showed stronger ability to inhibit trypsin digestion than older stock PMSF. For
this reason, fresh PMSF was made each week to be used in trypsin digestion runs for that
week. Conceding that some digestion will still be visible after a quenching step is added,
evaluation of protein digestion under different temperature and time conditions was
compared to the time 0 digestions.
Comparison of traditional incubation at different temperatures and times
Different temperatures of the traditional trypsin digestion protocol were compared
to establish a baseline as to how digestion at these temperatures would compare to
digestion at the same temperatures in a microwave. Temperatures that were tested under
traditional incubation conditions included 37°C, 45°C, 55°C and 65°C. A fifteen-minute
incubation time was selected for the temperature evaluation because most literature using
microwave assisted digestion suggested protein samples could be digested between a
range of seconds to 1-hour. Fifteen minutes was an average time within that range and
established enough digestion to determine an ideal temperature for protein digestion. It
has also been seen that an initial rapid increase in temperature can increase protein
digestion before it levels off (Collins & Leadbeater, 2007). The increase was seen in the
first 5 minutes so the 15-minute incubation time was able to cover this initial rapid
digestion followed by extra time to digest the sample after leveling off. After the ideal
temperature was established, different time trials of the traditional method were tested for
comparison to microwave assistance times. Based on the temperatures evaluated, 37°C
and 45°C appeared to show the most efficient protein digestion. Samples tested at these
temperatures showed only intermediate protein product bands at 5.8 and 7.9 kDa. The
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expected hemoglobin band at 12.9 kDa was not present. Samples tested at 55°C showed
multiple (6-7) intermediate product bands between 5.7 and 12.9 kDa. The strongest
protein band was seen at 12.9 kDa which is the expected size for the hemoglobin protein
suggesting minimal protein digestion at this temperature. Samples tested at 65°C also
showed multiple (5-6) intermediate product bands between 4.9 and 12.9 kDa. Again, the
strongest protein band present was the 12.9 kDa band, stronger than in the 55°C sample
suggesting even less protein digestion at this temperature.
Traditional protein digestion using trypsin was performed according to the
methods described above in the methods section and different incubation times were
compared. Incubation times of 30-minutes, 1-hour, 2-hours and overnight were evaluated
and were used to visually compare the amount of expected protein digestion during these
times. As was expected, the longer the incubation period the more protein digestion.
This was confirmed by bioanalyzer runs for each trial. Each digestion showed as the time
increased for each trial the intensity of the digested protein band decreased. For the
overnight digest of the blood sample there was a faint band present suggesting near
complete protein digestion. Outside of the system peak at 3.5 kDa, there was no band
present in the hemoglobin-HSA mixture sample. Also consistent across all samples was
an increase in intensity of the system peak at 3.5 kDa as the incubation time increased to
two hours then a decrease for the overnight incubation. This suggests a higher
concentration of smaller protein fragments at the 3.5kDa size and that more protein
digestion occurred as run time increased. Protein digestion involves breaking the protein
down ultimately into its smaller peptide components. The peptide components are too
small to be visualized on the bioanalyzer however the decrease in intensity at the 3.5 kDa
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as incubation time approached overnight suggest a decrease in protein fragments of this
size because they were digested further into the smaller peptide components.
Comparison of microwave incubation at different temperatures and times
Microwave assisted protein digestion was compared at different microwave
incubation temperatures and times. The different temperatures tested included 37°C,
45°C, 55°C and 65°C. Microwave temperature incubation trials were performed for 15minutes with a 3-minute ramp up to temperature and a 12-minute digestion at
temperature. Results for the microwave incubation were compared to the results from the
traditional incubation at the same temperatures. Based on the number of intermediate
digestion products present at each temperature, 37°C appeared to show the most efficient
digestion when microwave assistance was used. At 37°C only two intermediate digestion
products were present, none of which were the original hemoglobin band. When
compared to the traditional digestion method at 37°C for the same amount of time the
digestion patterns were similar between table top incubation and microwave assistance.
All other temperature trials showed between five and six intermediate digestion product
bands when digested with microwave assistance. Samples with microwave assistance at
55°C and 65°C showed similar intermediate digestion product suggesting inefficient
digestion at these temperatures. When compared to the traditional method, the digestion
band pattern was similar for the 55°C and 65°C trials. However, the intensity of the
smaller intermediate bands for the microwave assistance were stronger than the bands
seen in the traditional method. Also, while the hemoglobin band was present in both trial
methods, it was more intense in the traditional method than in the microwave assisted
method. This suggests that while the digestion was not most efficient at these
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temperatures, microwave assistance did provide better digestion than the traditional
method. This could be attributed to the increased digestion efficiency from ramping up
to temperature, as suggested by Collins et al. (2007). Traditional digestion at 45°C
showed better digestion than microwave assistance at 45°C. The traditional digestion
showed only two intermediate digestion products while the microwave assistance showed
5 intermediate digestion products including the original hemoglobin band. This suggests
that traditional incubation at 45°C is more efficient at protein digestion than microwave
assistance at the same temperature.
Microwave assisted protein digestion was tested at different times and compared
to traditional protein digestion for the same amount of time. Digestions were tested for
15-minutes, 30-minutes, 1-hour and 2-hours. Overnight time trials were performed using
the traditional method to compare microwave assisted digestion to traditional overnight
complete digestion. Digestions were performed at 37°C since this temperature was found
to be the ideal microwave assisted temperature. Each digestion time showed a single
intermediate digest product band at approximately 5.5 kDa. As digest time increased the
intensity of the 5.5 kDa intermediate band decreased suggesting increased protein
digestion as more time passed. The size of the intermediate protein fragment and the
intensity of the band was similar between microwave assisted and traditional incubator
digestions. None of the digested samples showed the 12.9 kDa hemoglobin band
suggesting that the larger protein molecule would be digested into smaller fragments in as
little as 15-minutes in both microwave assisted and incubator digestions. The 2-hour
digestion showed the most complete protein digestion when compared to the overnight
sample. This was expected as all previous results indicated the more time used to
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perform the digestion, the more the protein sample would be digested. These results
indicate similar results were achieved with microwave assisted digestion when compared
to traditional digestion on an incubator. Further research could be conducted to test if
more peptides were generated by one method over the other for the shortened digestion
periods and if there were enough peptides from the shorter digests to identify body fluids.
Comparison of buffers during microwave incubation
While preparing samples and testing different incubation conditions a need to
conserve reagents was realized. As with any research being conducted in a lab, one of
the goals should be to determine if the new procedure being tested will be cost effective.
In an attempt to make this procedure more cost effective, different buffer solutions were
tested. This was done to conserve reagents for samples that were not going to be
processed using mass spectrometry but where similar protein digestion results were
desired. The normal buffer used for the protein digestion is 500mM of
triethylammonium bicarbonate (TEAB). To conserve this reagent a 1:10 dilution to
50mM TEAB was made. The 500mM and 50mM TEAB were then compared to 50mM
ammonium bicarbonate (ABC) to test digestion efficiency between the three buffers.
Other than the different buffers, all other reagents and procedural steps were kept the
same. Microwave incubation was performed at 37°C for 15-minutes. Samples that were
resuspended in TEAB buffer (500mM or 50mM) showed a single intermediate band at
approximately 5.6 kDa while the ABC buffer (50mM) had two intermediate bands at 6.0
and 8.5 kDa. Based on this data all buffers showed that protein was able to be digested
when resuspended in them however the TEAB allowed for more protein digestion and
less intermediate protein bands after 15-minutes than ABC buffer. Furthermore, there
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was no major difference seen between the 500mM TEAB buffer and the 50mM TEAB
buffer suggesting that a diluted 50mM TEAB buffer could be used when resuspending
protein samples for digestion without a loss of digestion efficiency and with a possible
increase in cost savings.
Future considerations
This research suggests that microwave assistance may be used to digest protein
samples, however further research needs to be conducted to demonstrate increased
digestion efficiency while decreasing incubation time. In 2018, Dr. Donald Siegel of the
New York City OCME published a technical report for a National Institute of Justice
grant which, in part, expanded on the research conducted here regarding microwave
digestion of proteins. In this report he was able to show a direct improvement in protein
digestion efficiency through the use of microwave assistance. He also found increased
microwave power levels show similar digestion results to lower power levels and the
addition of organic solvents has the potential to increase digestion efficiency.
Siegel (2018) showed the effects of microwaves on trypsin digestion provide a
nearly 50% increase in digestion efficiency when compared to trypsin digestion in an
incubator. Using electropherograms of bioanalyzer results, the area under the curve of
undigested protein was measured and it was shown that in cases of microwave assisted
digestion, there was approximately 50% more undigested protein in samples digested in
an incubator versus samples digested in a microwave for the same amount of time
(Siegel, 2018). This finding expands on the research found in this thesis and strongly
suggests that microwaves can be beneficial to increasing protein digestion efficiency. In
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addition, an increase in the microwave power level was tested. Most common
microwaves run between 600 and 1200 watts and some research has been conducted with
both a scientific microwave and conventional microwave (Lin, Wu, Sun, Sun, & Ho,
2005). Similar to the research reported in this thesis, Siegel processed most of his
samples using 50 watts of power for the microwave. In his technical report a test was
performed where the microwave power level was increased to 850 watts and compared to
the digestions performed at 50 watts. Based on his results, Siegel found that the increase
in microwave power showed similar digestion efficiency between 50 watts and 850 watts.
Siegel (2018) also introduced organic solvents to his digestions to see what effect
these would have on digestions, both with and without microwave assistance. Research
has shown different solvent systems have been used and have shown efficient digestion
with the traditional method (Russell & Park, 2001). Lin et al. (2005) also found the use
of different organic solvent systems can increase digestion efficiency when combined
with microwave irradiation. Organic solvents can work as a denaturant to help unfold the
target protein and increase digestion efficiency. Addition of an organic solvent in the
digestion process can provide another means to increase digestion efficiency while
decreasing digestion time. Five different organic solvents were tested at the OCME;
acetone, acetonitrile, dimethyl sulfoxide, isopropanol and methanol. Following the same
comparison of area under the curve of undigested protein, Siegel found the addition of
organics showed an increase in digestion efficiency in all cases without microwave
assistance. Methanol and dimethyl sulfoxide saw approximately a 12.5% increase in
digestion while acetone, acetonitrile and isopropanol saw approximately a 25% increase.
In the case of organics with microwave assistance, all organic solvents except methanol
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saw an increase in digestion efficiency of approximately 34%. Methanol did not show a
significant increase in digestion efficiency with microwave assistance. Based on these
organic solvent results, Siegel (2018) found results similar to near overnight digestion of
protein samples can be achieved with a 20:1 (µg/µg) protein to trypsin ratio with
microwave assistance at 37°C for 30 minutes and 10% isopropanol.
Future research should include mass spectrometry runs of the sample times tested
and the peptide spectrums should be compared to that of an overnight digestion. This
would provide a more accurate understanding of how much digestion is occurring
through microwave irradiation alone. This may also provide information regarding the
peptide sequence and if a 15-minute digestion is long enough to provide adequate peptide
sequence for body fluid identification based on previously established markers. This type
of research could also be important in determining how much protein sample is needed to
produce enough peptide sequence for analysis. Identifying a lower limit for sample
protein input into the assay can directly affect how samples will be processed in a
laboratory. Research into enzymatic digestion has suggested replacing in solution trypsin
with immobilized trypsin for protein digestion (Lin, et al., 2008, B). This type of
digestion with microwave assistance was found to have high digestion efficiency in as
little as 15 seconds and could help reduce overall digestion times. Only blood
supernatant samples and samples prepared from powdered hemoglobin and human serum
albumin were used in this research. Other body fluid types that have previously been
tested and have marker profiles would also need to be tested under microwave irradiation
to ensure the same profiles can be obtained. If similar results can be obtained for the
different body fluid types then microwave digestion can be considered to enhance the
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procedure. Lastly testing could be performed to try to automate the system to increase
sample output while decreasing costs. The ability to use a diluted sample of TEAB
buffer can provide 10 times as much buffer reagent for use. This extra reagent could be
used on a plated system to increase the number of samples that can be prepared at one
time. Microwave digestion of the sample in a plate would need to be tested to see if this
could be beneficial.
The research conducted found that microwave assistance in protein digestion of
blood supernatant samples and hemoglobin-human serum albumin mixture samples is
best performed when the microwave temperature is set to 37°C. This digestion
temperature was found to be most comparable to traditional digestion on a table top
incubator. Microwave assisted digestion was tested at time trials of 15-minutes, 30minutes, 1-hour and 2-hours and was compared to traditional digestion at those same
times as well as overnight digestion. The microwave assistance was found to produce
similar results to traditional digestion on a table top incubator for the tested times.
Longer digestion times did show better digestion, consistent with the table top incubator.
None of the digestion times showed the near complete digestion seen during overnight
incubation. In testing reagent use for cost savings, it was found that a dilution of the
500mM TEAB buffer to 50mM TEAB can produce similar protein digestion results and
potentially save on future reagent costs.
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Appendix

Figure 18. Example electropherogram. This electropherogram was taken from the
traditional incubation run at 55°C for 15 minutes. Each distinct peak in the run is
represented by a band on the gel image.

Figure 19. Electropherogram representing traditional incubation at 65°C for 15 minutes.
A large dip below baseline can be seen between peaks 2.3 and 3.1 indicating an error in
the run and giving the gel image a blue tint.
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Figure 20. Traditional trypsin protein digestion of blood sample for 30-minutes.
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Figure 21. Traditional trypsin protein digestion of hemoglobin/HSA sample for 30minutes.

81

Figure 22. Traditional trypsin protein digestion of blood sample for 1-hour.
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Figure 23. Traditional trypsin protein digestion of hemoglobin/HSA sample for 1-hour.
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Figure 24. Traditional trypsin protein digestion of blood sample for 2-hours.
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Figure 25. Traditional trypsin protein digestion of hemoglobin/HSA sample for 2-hours.
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Figure 26. Traditional trypsin protein digestion of blood sample overnight.

86

Figure 27. Traditional trypsin protein digestion of hemoglobin/HSA sample overnight.
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Figure 28. 5-minute microwave digestion compared to incubator digestion.
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Figure 29. 10-minute microwave digestion compared to incubator digestion.
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Preparation of gel-dye mix and de-staining solution for the Agilent Protein 230 Kit
The reagents were removed from 4°C storage and allowed to sit at room
temperature for 30 minutes to equilibrate. Twenty-five microliters of Protein 230 dye
concentrate were added to 650 µl of a stock tube of Protein 230 gel matrix creating a geldye mix. The tube was vortexed using a vortex mixer (Fisher Scientific, Waltham, USA)
for 10 seconds and spun down for 15 seconds. The entire gel-dye mix was transferred to
the top receptacle of a spin filter tube. The tube was labeled with “Protein 230 gel-dye
mix” and the date it was prepared. To prepare the de-staining solution, a separate tube of
Protein 230 gel matrix was obtained and all 650 µl was transferred to the top receptacle
of a new spin filter tube. This tube was labeled with “Protein 230 DS” and the date it was
prepared. Both spin filters were placed in a 5415D Eppendorf Microcentrifuge
(Hamburg, Germany) and spun at room temperature for 15 minutes at 2500 x g ± 20%.
The gel-dye mix had an expiration date four weeks after the preparation date, the destaining solution was good through the use of the kit.
Preparation of gel-dye mix and de-staining solution for the Agilent Protein 80 Kit
The reagents were removed from 4°C storage and allowed to sit at room
temperature for 30 minutes to equilibrate. Two tubes of Protein 80 gel matrix were
obtained. All 650 µl of each tube was added to the top receptacle of two separate spin
filter tubes. One spin filter tube was labeled with “Protein 80 gel-dye mix” and the date
prepared while the other was labeled with “Protein 80 DS” and the date prepared. Both
spin filters were placed in a 5415D Eppendorf Microcentrifuge (Hamburg, Germany) and
spun at room temperature for 15 minutes at 2500 x g ± 20%. To the tube labeled “Protein
80 gel-dye mix”, 25 µl of Protein 80 dye concentrate was added. The tube was vortexed
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for 10-20 seconds until a uniform color was obtained. The gel-dye mix had an expiration
date four weeks after the preparation date, the de-staining solution was good through the
use of the kit.
Preparation of Denaturing Solution, Samples and Ladder
For both the Agilent Protein 80 and Agilent Protein 230 kits, the same preparation
steps for the denaturing solution, samples and ladder were taken. A stock of 1M
dithiothreitol (DTT) was made by combining 0.154 g of DTT (Sigma Aldrich, St. Louis,
USA) in 1 mL of ddH2O. Aliquots of 100 µl were transferred to 1.5 mL tubes and each
tube was labeled with “DTT” and the preparation date. These tubes were stored at -20°C.
An aliquot of DTT was thawed and 7 µl of the DTT solution was mixed with 200 µl of
sample buffer from the appropriate Agilent Protein kit to create the denaturing solution.
The denaturing solution was stored at 4°C and would expire two weeks after the
preparation date. To start sample and ladder preparation the denaturing solution and the
proper kit ladder were allowed to sit out for 30 minutes at room temperature to
equilibrate. Samples, ladder and denaturing solution were vortexed. In a 0.5 mL tube 4
µl of sample was combined with 2 µl of denaturing solution. Tubes were vortexed well
and the solution was spun to the bottom of the tube. In a separate 0.5 mL tube 6 µl of the
appropriate kit ladder with no denaturing solution was added. The 0.5 mL tube
containing sample or ladder was placed on a heat block (Eppendorf Thermomixer,
Hamburg, Germany) and the samples were heat denatured at 95-100°C for 5 minutes.
The tubes were allowed to cool for 10 seconds then spun them for 15 seconds to pull the
sample volume to the bottom of the tube. To each sample or ladder tube 84 µl of ddH 2O
was added and tubes were vortexed.
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Preparing the chip for the Agilent Protein 230 Kit
Figure 30 below shows the placement of gel-dye and de-staining solution for
preparing the Agilent Protein 230 chip. The chip is labeled with which solution is to be
added to each well. Twelve microliters of gel-dye were added to the upper right most
well and the chip was placed in the priming station. The plunger was depressed on the
syringe and held in place with a clip for 60 seconds. After 60 seconds the plunger was
released, the chip was removed and any remaining gel-dye was removed from the well.
To each well labeled to receive gel-dye, 12 µl of gel dye were added (four wells). To the
bottom right most well 12 µl of de-staining solution were added.

Figure 30: Diagram of placement of gel-dye and de-staining solution on the microfluidic
chip for the Agilent Protein 230 Kit (Agilent Technologies, Inc., 2011).
Preparing the chip for the Agilent Protein 80 Kit
Figure 31 below shows the placement of gel-dye and de-staining solution for
preparing the Agilent Protein 80 chip. The chip is labeled with which solution is to be
added to each well. Twelve microliters of gel-dye were added to the upper right most
well and the chip is placed in the priming station. The plunger is depressed on the
syringe and held with a clip for 60 seconds. After 60 seconds the plunger was released
and the chip was removed. To each remaining well labeled to receive gel-dye, 12 µl of
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gel dye were added (three wells). To the bottom right most well 12 µl of de-staining
solution were added.

Figure 31: Diagram of placement of gel-dye and de-staining solution on the microfluidic
chip for the Agilent Protein 80 Kit (Agilent Technologies, Inc., 2011).
Loading the sample and ladder and running the assay
Figure 32 below shows the placement of all samples and ladder on the chip. A
single chip is capable of running up to 10 samples and 1 ladder per chip. To each sample
well 6 µl of sample was added. To the ladder well 6 µl of ladder was added.

Figure 32: Diagram of placement of samples and ladder on the microfluidic chip for both
the Agilent Protein 80 and Protein 230 Kits (Agilent Technologies, Inc., 2011).
After all samples and ladder were loaded onto the chip, the chip was placed on the
Agilent 2100 Bioanalyzer (Agilent Technologies, Santa Clara, USA). Using the
bioanalyzer software, the assay being performed was selected, Protein 230 Series II or
Protein 80 Series II. A simple run name, using the date of the run followed by the
number run of the day, was created to save the run data. Once the assay and file name
were selected the user pressed start on the instrument tab and the run was started. After
the run was complete the chip was removed. Three-hundred and fifty microliters of
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ddH2O were added to a well on the cleaning chip and the chip was placed on the
instrument for 10 seconds to clean the electrodes.

